W J Shang1, L M Shu1,2, X Zhou3, H Q Liao2, X H Chen1, H Hong1, H B Chen4. 1. Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong Province, China. 2. Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, NO. 628 Zhenyuan Road, Shenzhen, 518107, China. 3. Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-Sen University, No. 2nd Zhongshan Road, Guangzhou, 510080, China. 4. Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, Guangdong Province, China. shark2860@sina.com.
Abstract
PURPOSE: The clinical significance of FLAIR vascular hyperintensity (FVH), a marker of collateral circulation in ischaemic stroke, remains controversial. We hypothesised that the association between FVH and outcomes varies with the severity of leukoaraiosis (LA), another marker of collaterals, and that their combined significance may vary with time. METHODS: We included 459 consecutive patients with middle cerebral artery (MCA) stroke. Proximal and distal FVHs were distinguished based on location. LA was divided into two grades, according to Fazekas scores of 0-2 and 3-6. Symptom-to-MRI time was divided into two categories: ≤ 14 days and ≥ 15 days. RESULTS: We found no difference in FVH proportion according to LA grade. Multivariate analysis revealed that LA and FVH status were independently associated with unfavourable outcomes (modified Rankin scale ≥ 2) in patients with symptom-to-MRI times ≤ 14 days (P = 0.008), but not in those with symptom-to-MRI times ≥15 days (P = 0.61). In the group with symptom-to-MRI times ≤14 days, patients with LA 3-6 and FVH(+) (OR, 3.044; 95% CI, 1.116-8.305) were more likely to have unfavourable clinical outcomes compared with patients with LA 0-2 and FVH(+) but not compared with those with LA 0-2 and FVH(-) or LA 3-6 and FVH(-). In addition, FVH location did not influence the relationship between FVH and outcomes. CONCLUSIONS: The association between FVH and outcomes was influenced by the degree of LA in the acute but not in the subacute and chronic stages of MCA infarction. FVH predicts clinical outcomes independently only in those with more extensive LA.
PURPOSE: The clinical significance of FLAIR vascular hyperintensity (FVH), a marker of collateral circulation in ischaemic stroke, remains controversial. We hypothesised that the association between FVH and outcomes varies with the severity of leukoaraiosis (LA), another marker of collaterals, and that their combined significance may vary with time. METHODS: We included 459 consecutive patients with middle cerebral artery (MCA) stroke. Proximal and distal FVHs were distinguished based on location. LA was divided into two grades, according to Fazekas scores of 0-2 and 3-6. Symptom-to-MRI time was divided into two categories: ≤ 14 days and ≥ 15 days. RESULTS: We found no difference in FVH proportion according to LA grade. Multivariate analysis revealed that LA and FVH status were independently associated with unfavourable outcomes (modified Rankin scale ≥ 2) in patients with symptom-to-MRI times ≤ 14 days (P = 0.008), but not in those with symptom-to-MRI times ≥15 days (P = 0.61). In the group with symptom-to-MRI times ≤14 days, patients with LA 3-6 and FVH(+) (OR, 3.044; 95% CI, 1.116-8.305) were more likely to have unfavourable clinical outcomes compared with patients with LA 0-2 and FVH(+) but not compared with those with LA 0-2 and FVH(-) or LA 3-6 and FVH(-). In addition, FVH location did not influence the relationship between FVH and outcomes. CONCLUSIONS: The association between FVH and outcomes was influenced by the degree of LA in the acute but not in the subacute and chronic stages of MCA infarction. FVH predicts clinical outcomes independently only in those with more extensive LA.
Entities:
Keywords:
FLAIR vascular hyperintensity; Ischaemic stroke; Leukoaraiosis; Magnetic resonance imaging
Authors: A Kufner; I Galinovic; V Ambrosi; C H Nolte; M Endres; J B Fiebach; M Ebinger Journal: AJNR Am J Neuroradiol Date: 2015-05-14 Impact factor: 3.825
Authors: E Mahdjoub; G Turc; L Legrand; J Benzakoun; M Edjlali; P Seners; S Charron; W Ben Hassen; O Naggara; J-F Meder; J-L Mas; J-C Baron; C Oppenheim Journal: AJNR Am J Neuroradiol Date: 2017-10-26 Impact factor: 3.825
Authors: Bastian Cheng; Martin Ebinger; Anna Kufner; Martin Köhrmann; Ona Wu; Dong-Wha Kang; David Liebeskind; Thomas Tourdias; Oliver C Singer; Soren Christensen; Steve Warach; Marie Luby; Jochen B Fiebach; Jens Fiehler; Christian Gerloff; Götz Thomalla Journal: Stroke Date: 2012-08-28 Impact factor: 7.914
Authors: Dezhi Liu; Fabien Scalzo; Neal M Rao; Jason D Hinman; Doojin Kim; Latisha K Ali; Jeffrey L Saver; Wen Sun; Qiliang Dai; Xinfeng Liu; David S Liebeskind Journal: Stroke Date: 2016-09-22 Impact factor: 7.914
Authors: Alexander H Nave; Anna Kufner; Philipp Bücke; Eberhard Siebert; Stefan Kliesch; Ulrike Grittner; Hansjörg Bäzner; Thomas Liebig; Matthias Endres; Jochen B Fiebach; Christian H Nolte; Martin Ebinger; Hans Henkes Journal: Stroke Date: 2018-02-19 Impact factor: 7.914
Authors: Si Eun Kim; Byung In Lee; Sung Eun Kim; Kyong Jin Shin; JinSe Park; Kang Min Park; Hyung Chan Kim; Joonwon Lee; Hye Jin Baek; Sung-Cheol Jin; Sam Yeol Ha Journal: Stroke Date: 2016-05-05 Impact factor: 7.914